As of 2026-09-14, the Relative Valuation of THC Biomed Intl Ltd (THC.CN) is (0.15) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of THC Biomed Intl Ltd based on Relative Valuation is -872.6%.
The range of the Relative Valuation is (0.14) - (0.16) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 2.4x - 3.5x | 3.0x |
| Forward P/E multiples | 3.2x - 4.7x | 4.0x |
| Fair Price | (0.14) - (0.16) | (0.15) |
| Upside | -807.7% - -892.8% | -872.6% |
| Date | P/E |